Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pacemaker cell electrical activity refers to the cyclical generation of spontaneous action potentials in specialized cardiac cells (mainly in the sinoatrial node). These cells exhibit a slow, progressive depolarization (pacemaker potential) due to a coordinated activity of ion channels—primarily HCN (funny) channels, voltage-gated calcium channels, and potassium channels. This electrical rhythm sets the heart rate and ensures proper beating of the heart. Disruption in pacemaker cell electrical activity can lead to arrhythmias or the need for artificial pacemakers. Drugs targeting specific ion channels (e.g., ivabradine for the funny current) can modulate pacemaker activity as a therapeutic strategy.
Blockade of HCN/funny current (reduces automaticity) Inhibition of Ca^2+ channels (slows heart rate) Modulation of potassium channel activity
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sinoatrial node pacemaker cell electrical activity.